Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Aumento rispetto a cure potenziate basate sulla difesa come al solito per i pazienti che vivono IPV (RISE)

27 settembre 2026 aggiornato da: Boston University

Recupero dall'IPV attraverso punti di forza e potenziamento (aumento) rispetto a cure potenziate basate sulla difesa come al solito per i pazienti che hanno avuto IPV

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health.

Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

172

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Massachusetts
      • Boston, Massachusetts, Stati Uniti, 02130
        • Reclutamento
        • VA Boston Healthcare System
        • Contatto:
          • Katherine M Iverson, PhD
    • Minnesota
      • Minneapolis, Minnesota, Stati Uniti, 55417
        • Reclutamento
        • VA Minneapolis Healthcare System
        • Contatto:
          • Princess Ackland, PhD
    • Pennsylvania
      • Philadelphia, Pennsylvania, Stati Uniti, 19104
        • Reclutamento
        • VA Philadelphia Healthcare System
        • Contatto:
          • Melissa Dichter, PhD

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
  • report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
  • be able to provide informed consent including permission to have intervention sessions recorded

Exclusion Criteria:

  • severe cognitive impairment,
  • suicide or homicide intent with a specific plan
  • untreated or unstable symptoms of mania or psychosis

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: RISE (Recovering from Intimate Partner Violence through Strengths and Empowerment)

Participants randomized to the RISE arm will have 1 or more RISE sessions.

RISE is personalized, trauma-informed, empowerment-oriented and variable-length, consisting of an initial 60-minute session and up to 7 additional 45-minute sessions (1-8 sessions total).

Comparatore attivo: Advocacy-based ECAU (Enhanced Care as Usual)

Participants randomized to this arm will have a single Advocacy-based ECAU session

Advocacy-based ECAU is a single 60-minute trauma-informed counseling intervention that includes supportive education, validating and empathetic statements, safety planning, resource provision and referrals.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Self-efficacy
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Self-efficacy will be assessed with the General Self-Efficacy Scale (GSES), a 10-item instrument with possible responses for each item from 1 to 4 where 1= Not at all true, 2= Hardly true, 3= Moderately true, and 4=Exactly true.Scores can range from 10 to 40 and higher scores indicate more self efficacy.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Depressive symptoms
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Depressive symptoms will be assessed with the Center for Epidemiologic Studies Depression Scale (CESD), a 20-item instrument with possible responses for each item from 0 to 3 where 0= Rarely or none of the time (less than 1 day), 1= Some or a little of the time (1-2 days), 2= Occasionally or a moderate amount of the time (3-4 days), and 3= Most or all of the time (5-7 days). Possible range of scores is 0 to 60, with the higher scores indicating more depressive symptoms.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Post traumatic stress disorder (PTSD) symptoms
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

PTSD symptoms will be assessed with the PTSD Checklist -DSM-5, a 20-item self-report measure of the DSM-5 symptoms of PTSD. A 5-point Likert scale is used for each item from 0 = "Not at all" to 4 = "Extremely". Total possible scores can range from 0 to 80 with higher scores indicating more PTSD symptoms.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Alcohol use
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Alcohol use will be assessed with the Alcohol Use Disorders Identification Test-10 (AUDIT-10), a 10-item instrument with possible responses for each item from 0 to 4 for questions 1-8 and possible responses of 0, 2, and 4 for questions 9 and 10. Total possible scores can range from 0 to 40 with higher scores indicating greater alcohol use.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Hopelessness
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Hopelessness will be assessed by the 20-item Beck Hopelessness Scale (BHS). The BHS is scored by adding up the responses to 20 true-false questions. The possible score range is 0-20, with higher scores indicating greater hopelessness.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Self-reported quality of life
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Quality of life will be assessed by World Health Organization - Quality of Life, Brief WHOQOL-BREF instrument, a 26-item instrument consisting of four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains QOL and general health items. Each individual item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale. The scores are then transformed linearly to a 0-100-scale with higher scores indicating a better quality of life.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Valued living
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Valued living will be assessed with the Valued Living Questionnaire (VLQ) focusing on 10 valued domains of living which include (1) family, (2) marriage/couples, intimate relations, (3) parenting, (4) friendship, (5) work, (6) education, (7) recreation, (8) spirituality, (9) citizenship, and (10) physical self-care. Each domain is rated on a scale of 1-10, based on the level of importance to the respondent and the extent to which they have lived consistent with their values in the past week. A total score is calculated by multiplying the importance and consistency ratings for each domain, and then averaging those scores. Total scores range from 10 to 100 with higher scores indicating greater alignment with one's values.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
IPV
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Experiences of IPV from past or a current intimate partner will be measured using subscales of the Revised Conflict Tactics Scale (CTS-2). The physical aggression (12 items), psychological aggression (8 items), and sexual coercion (7 items) subscales include 27 items regarding the frequency of different IPV experiences (0=this has never happened, 1=1 time, 2=2 times, 3=3-5 times, 4=6-10 times, 5=11-20 times, and 6=20+ times). Items are summed for a total frequency score. Additionally, the number of different IPV behaviors experienced can be tallied to reflect a indicate the number of different IPV behaviors experienced. Higher scores reflect greater levels of IPV experience.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Measure of Victim Empowerment Related to Safety
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Safety-related Empowerment will be measured with the Measure of Victim Empowerment Related to Safety (MOVERS), a 13- item measure that consists of three subscales: internal resources (6 items), expectations of support (4 items), and trade-offs (3 items), with response options on a scale from 1-5, with 1 being "never true" and 5 being "always true" for each internal resource and expectation of support subscale question. Responses options for the trade-off subscale are reverse scored with 1 = Always true and 5= Never true. Total possible scores can range from 13 to 65, with higher scores indicating higher levels of empowerment.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
Health care and social service use
Lasso di tempo: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Items adapted from the National Survey of Veterans and prior studies examining health and social service use among individuals experiencing IPV, particularly in terms of VA and non-VHA psychosocial health services (e.g., mental health, housing, domestic violence agencies). The number and types of psychosocial treatment services will be examined.

Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
VHA health care use
Lasso di tempo: 12 months before baseline, 12 months after baseline

VHA health care use will be extracted from the electronic medical records. The types and number of services used, particularly psychosocial health services, will be examined.

12 months before baseline, 12 months after baseline
Treatment satisfaction
Lasso di tempo: 3 months

Treatment satisfaction will be assessed using the 8-item Client Satisfaction Questionnaire-8 (CSQ-8). Possible scores range from 8 to 32, with higher values indicating higher treatment satisfaction.

3 months
Perceived Benefits/Harms
Lasso di tempo: 3 months

Perceived benefits/harms from participating in the interventions will be measured using 6 items adapted from prior studies. Possible responses on a Likert scale range from 1= strongly disagree to 5 = strongly agree, with item 4 reverse scored. Individual item scores and total scores will be examined.

3 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Katherine M Iverson, PhD, V Boston Healthcare System, BU CASchool Medicine Psychiatry
  • Investigatore principale: Melissa Dichter, PhD MSW, VA Philadelphia Healthcare System

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 settembre 2025

Completamento primario (Stimato)

1 gennaio 2030

Completamento dello studio (Stimato)

1 gennaio 2030

Date di iscrizione allo studio

Primo inviato

1 aprile 2025

Primo inviato che soddisfa i criteri di controllo qualità

1 aprile 2025

Primo Inserito (Effettivo)

2 aprile 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

30 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

27 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • H-45215
  • BPS-2023C2-33320 (Altro numero di sovvenzione/finanziamento: PCORI)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .